SCHEMBL13870929

SCHEMBL13870929

COc1cc(OC)c2ccc(-c3cc(C)c(C)cc3C)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.51
ALDH1A1 P00352 6/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
HPGD P15428 5/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
DHFR P00374 3/20 0.40
HSD17B10 Q99714 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 2/20 0.38
PDGFRB P09619 2/20 0.38
PDGFRA P16234 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870926 0.86 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL13870925 0.86 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL8888130 0.84 KDM4E (0.57) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL16487815 0.82 KDM4E (0.39) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL13870927 0.82 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL13870928 0.82 KDM4E (0.53) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL13870947 0.80 PSMB5 (0.44) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL13870911 0.78 KDM4E (0.56) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL13870938 0.77 NQO2 (0.46) KDM4EALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL28273064 0.77 KDM4E (0.53) KDM4EALDH1A1SMN1; SMN2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 KDM4E 2874/4885ALDH1A1 111/4885SMN1; SMN2 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.